Kjetil Retterstøl

  • Professor
  • +47 230 75617 / 90098393
 

Original articles

Krogh HW, Svendsen K, Igland J, Mundal LJ, Holven KB, Bogsrud MP, Leren TP, Retterstøl K (2019)
Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
Sci Rep, 9 (1), 19273
DOI 10.1038/s41598-019-55682-x, PubMed 31848411

Narverud I, Christensen JJ, Bakke SS, Ulven SM, Rundblad A, Aukrust P, Espevik T, Bogsrud MP, Retterstøl K, Ueland T, Halvorsen B, Holven KB (2019)
Profiling of immune-related gene expression in children with familial hypercholesterolaemia
J Intern Med
DOI 10.1111/joim.13001, PubMed 31631426

Mundal LJ, Hovland A, Igland J, Veierød MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstøl K (2019)
Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia
JAMA Cardiol, 4 (11), 1156-1159
DOI 10.1001/jamacardio.2019.3903, PubMed 31617858

Øyri LKL, Bogsrud MP, Kristiansen AL, Myhre JB, Retterstøl K, Brekke HK, Gundersen TE, Andersen LF, Holven KB (2019)
Infant cholesterol and glycated haemoglobin concentrations vary widely-Associations with breastfeeding, infant diet and maternal biomarkers
Acta Paediatr, 109 (1), 115-121
DOI 10.1111/apa.14936, PubMed 31299108

Narverud I, Bogsrud MP, Øyri LKL, Ulven SM, Retterstøl K, Ueland T, Mulder M, Roeters van Lennep J, Halvorsen B, Aukrust P, Veierød MB, Holven KB (2019)
Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia
Br J Nutr, 122 (7), PII S0007114519001600-799
DOI 10.1017/S0007114519001600, PubMed 31262370

Wisløff T, Mundal LJ, Retterstøl K, Igland J, Kristiansen IS (2019)
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
Atherosclerosis, 287, 140-146
DOI 10.1016/j.atherosclerosis.2019.06.900, PubMed 31280039

Christensen JJ, Bakke SS, Ulven SM, Retterstøl K, Henriksen T, Bollerslev J, Espevik T, Aukrust P, Halvorsen B, Holven KB (2019)
Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children
Mol Nutr Food Res, 63 (7), e1800990
DOI 10.1002/mnfr.201800990, PubMed 30702198

Svendsen K, Jacobs DR, Røyseth IT, Garstad KW, Byfuglien MG, Granlund L, Mørch-Reiersen LT, Telle-Hansen VH, Retterstøl K (2019)
Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening
Eur J Public Health, 29 (1), 17-23
DOI 10.1093/eurpub/cky190, PubMed 30239673

Bogsrud MP, Græsdal A, Johansen D, Langslet G, Hovland A, Arnesen KE, Mundal LJ, Retterstøl K, Wium C, Holven KB (2019)
LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia
J Clin Lipidol, 13 (2), 279-286
DOI 10.1016/j.jacl.2019.01.010, PubMed 30910667

Urke EB, Søbye S, Ellingvåg A, Langslet G, Retterstøl K, Wandel M (2018)
Familial hypercholesterolemia and young patients' thoughts on own condition and treatment
Patient Educ Couns, 102 (5), 1005-1012
DOI 10.1016/j.pec.2018.12.025, PubMed 30606641

Hovland A, Mundal LJ, Igland J, Veierød MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstøl K (2018)
Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia
Stroke, 50 (1), 172-174
DOI 10.1161/STROKEAHA.118.023456, PubMed 30580708

Drivdal M, Holven KB, Retterstøl K, Aagenaes Ø, Kase BF (2018)
A nine year follow-up study of patients with lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome)
Scand J Clin Lab Invest, 78 (7-8), 566-574
DOI 10.1080/00365513.2018.1519723, PubMed 30755100

Retterstøl K, Svendsen M, Narverud I, Holven KB (2018)
Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study
Atherosclerosis, 279, 52-61
DOI 10.1016/j.atherosclerosis.2018.10.013, PubMed 30408717

Korman MJ, Retterstøl K, Kristiansen IS, Wisløff T (2018)
Are PCSK9 Inhibitors Cost Effective?
Pharmacoeconomics, 36 (9), 1031-1041
DOI 10.1007/s40273-018-0671-0, PubMed 29777433

Svendsen K, Telle-Hansen VH, Mørch-Reiersen LT, Garstad KW, Thyholt K, Granlund L, Henriksen HB, Gran JM, Jacobs DR, Retterstøl K (2018)
A randomized controlled trial in Norwegian pharmacies on effects of risk alert and advice in people with elevated cardiovascular risk
Prev Med Rep, 12, 79-86
DOI 10.1016/j.pmedr.2018.08.004, PubMed 30191097

Svendsen K, Henriksen HB, Østengen B, Jacobs DR, Telle-Hansen VH, Carlsen MH, Retterstøl K (2018)
Evaluation of a short Food Frequency Questionnaire to assess cardiovascular disease-related diet and lifestyle factors
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1370, PubMed 29720928

Mundal LJ, Igland J, Veierød MB, Holven KB, Ose L, Selmer RM, Wisloff T, Kristiansen IS, Tell GS, Leren TP, Retterstøl K (2018)
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-1607
DOI 10.1136/heartjnl-2017-312706, PubMed 29622598

Holven KB, Narverud I, van Lennep JR, Versmissen J, Øyri LKL, Galema-Boers A, Langslet G, Ulven SM, Veierød MB, Retterstøl K, Bogsrud MP (2018)
Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH
J Clin Lipidol, 12 (3), 748-755.e2
DOI 10.1016/j.jacl.2018.02.021, PubMed 29609857

Hope S, Nordstrøm M, Retterstøl K, Iversen PO, Kolset SO (2018)
The right to a health-promoting diet for people with intellectual disabilities
Tidsskr Nor Laegeforen, 138 (2)
DOI 10.4045/tidsskr.17.0985, PubMed 29357630

Hovland A, Nestvold T, Bohov P, Trøseid M, Aukrust P, Berge RK, Waage-Nielsen E, Retterstøl K, Lappegård KT (2017)
Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Scand J Clin Lab Invest, 77 (8), 628-633
DOI 10.1080/00365513.2017.1393691, PubMed 29069988

Hovland A, Mundal LJ, Igland J, Veierød MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstøl K (2017)
Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
Atherosclerosis, 266, 69-73
DOI 10.1016/j.atherosclerosis.2017.09.027, PubMed 28992466

Christensen JJ, Ulven SM, Retterstøl K, Narverud I, Bogsrud MP, Henriksen T, Bollerslev J, Halvorsen B, Aukrust P, Holven KB (2017)
Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study
Atherosclerosis, 266, 48-57
DOI 10.1016/j.atherosclerosis.2017.09.021, PubMed 28963918

Retterstøl K, Narverud I, Selmer R, Berge KE, Osnes IV, Ulven SM, Halvorsen B, Aukrust P, Holven KB, Iversen PO (2017)
Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Lipids Health Dis, 16 (1), 115
DOI 10.1186/s12944-017-0511-9, PubMed 28606150

Gjevestad GO, Ottestad I, Biong AS, Iversen PO, Retterstøl K, Raastad T, Skålhegg BS, Ulven SM, Holven KB (2017)
Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
Mech Ageing Dev, 162, 1-8
DOI 10.1016/j.mad.2017.01.011, PubMed 28163108

Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2017)
Intake of a Protein-Enriched Milk and Effects on Muscle Mass and Strength. A 12-Week Randomized Placebo Controlled Trial among Community-Dwelling Older Adults
J Nutr Health Aging, 21 (10), 1160-1169
DOI 10.1007/s12603-016-0856-1, PubMed 29188875

Christensen JJ, Osnes LT, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Atherosclerosis, 256, 67-74
DOI 10.1016/j.atherosclerosis.2016.11.031, PubMed 28024183

Mundal L, Igland J, Ose L, Holven KB, Veierød MB, Leren TP, Retterstøl K (2016)
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur J Prev Cardiol, 24 (2), 137-144
DOI 10.1177/2047487316676135, PubMed 27794106

Ottestad I, Nordvi B, Vogt G, Holck M, Halvorsen B, Brønner KW, Retterstøl K, Holven KB, Nilsson A, Ulven SM (2016)
Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study
J Nutr Sci, 5, e43
DOI 10.1017/jns.2016.34, PubMed 28620470

Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K (2016)
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur J Prev Cardiol, 23 (18), 1962-1969
DOI 10.1177/2047487316666371, PubMed 27558979

Christensen JJ, Retterstøl K, Godang K, Roland MC, Qvigstad E, Bollerslev J, Ueland T, Henriksen T, Holven KB (2016)
LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
J Clin Lipidol, 10 (6), 1369-1378.e7
DOI 10.1016/j.jacl.2016.08.016, PubMed 27919354

Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterstøl K, Ellingvåg A, Strøm E, Ose L, Veierød MB, Holven KB (2016)
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-27
DOI 10.1016/j.atherosclerosis.2016.07.913, PubMed 27494447

Halvorsen B, Santilli F, Scholz H, Sahraoui A, Gulseth HL, Wium C, Lattanzio S, Formoso G, Di Fulvio P, Otterdal K, Retterstøl K, Holven KB, Gregersen I, Stavik B, Bjerkeli V, Michelsen AE, Ueland T, Liani R, Davi G, Aukrust P (2016)
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
Diabetologia, 59 (10), 2134-44
DOI 10.1007/s00125-016-4036-y, PubMed 27421726

Pingitore P, Lepore SM, Pirazzi C, Mancina RM, Motta BM, Valenti L, Berge KE, Retterstøl K, Leren TP, Wiklund O, Romeo S (2016)
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
J Clin Lipidol, 10 (4), 816-823
DOI 10.1016/j.jacl.2016.02.015, PubMed 27578112

Holme I, Retterstøl K, Norum KR, Hjermann I (2016)
Lifelong benefits on myocardial infarction mortality: 40-year follow-up of the randomized Oslo diet and antismoking study
J Intern Med, 280 (2), 221-7
DOI 10.1111/joim.12485, PubMed 26924204

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K (2016)
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials
Br J Nutr, 115 (3), 466-79
DOI 10.1017/S0007114515004699, PubMed 26768850

Nordstrom M, Paus B, Retterstol K, Kolset SO (2016)
The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader-Willi syndrome, and Down syndrome
J. Intellect. Dev. Dis., 41 (3), 187-196

Krogh HW, Mundal L, Holven KB, Retterstøl K (2015)
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Eur Heart J, 37 (17), 1398-405
DOI 10.1093/eurheartj/ehv602, PubMed 26586781

Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB (2015)
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Atherosclerosis, 243 (1), 155-60
DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212

Langslet G, Bogsrud MP, Halvorsen I, Fjeldstad H, Retterstøl K, Veierød MB, Ose L (2015)
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
J Clin Lipidol, 9 (6), 778-785
DOI 10.1016/j.jacl.2015.08.008, PubMed 26687698

Tjelle TE, Holtung L, Bøhn SK, Aaby K, Thoresen M, Wiik SÅ, Paur I, Karlsen AS, Retterstøl K, Iversen PO, Blomhoff R (2015)
Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers
Br J Nutr, 114 (7), 1054-63
DOI 10.1017/S0007114515000562, PubMed 26227795

Koopal C, Retterstøl K, Sjouke B, Hovingh GK, Ros E, de Graaf J, Dullaart RP, Bertolini S, Visseren FL (2015)
Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study
Atherosclerosis, 240 (1), 90-7
DOI 10.1016/j.atherosclerosis.2015.02.046, PubMed 25768710

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2014)
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
DOI 10.1161/JAHA.114.001236, PubMed 25468658

Berge KE, Retterstøl K, Romeo S, Pirazzi C, Leren TP (2014)
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
Atherosclerosis, 234 (1), 30-3
DOI 10.1016/j.atherosclerosis.2014.02.005, PubMed 24589565

Holven KB, Narverud I, Lindvig HW, Halvorsen B, Langslet G, Nenseter MS, Ulven SM, Ose L, Aukrust P, Retterstøl K (2014)
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-7
DOI 10.1016/j.atherosclerosis.2014.01.022, PubMed 24530965

Holven KB, Retterstøl K, Ueland T, Ulven SM, Nenseter MS, Sandvik M, Narverud I, Berge KE, Ose L, Aukrust P, Halvorsen B (2013)
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
PLoS One, 8 (11), e78241
DOI 10.1371/journal.pone.0078241, PubMed 24244297

Molven I, Retterstøl K, Andersen LF, Veierød MB, Narverud I, Ose L, Svilaas A, Wandel M, Holven KB (2013)
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
DOI 10.1017/jns.2013.27, PubMed 25191582

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
DOI 10.1007/s40291-013-0031-x, PubMed 23580084

Bogsrud MP, Reikvam Å, Retterstøl K (2013)
[Treatment with statins]
Tidsskr Nor Laegeforen, 133 (12-13), 1316-9
DOI 10.4045/tidsskr.12.0825, PubMed 23817262

Baumann M, Espeland MZ, Kværner AS, Bogsrud MP, Retterstøl K (2013)
[Lipid profile of healthy persons with low-carbohydrate diet]
Tidsskr Nor Laegeforen, 133 (11), 1193-6
DOI 10.4045/tidsskr.12.0034, PubMed 23759780

Ottestad I, Ose L, Wennersberg MH, Granlund L, Kirkhus B, Retterstøl K (2013)
Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial
Atherosclerosis, 228 (2), 421-5
DOI 10.1016/j.atherosclerosis.2013.03.001, PubMed 23623012

Bogsrud MP, Langslet G, Ose L, Arnesen KE, Sm Stuen MC, Malt UF, Woldseth B, Retterstøl K (2013)
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Scand Cardiovasc J, 47 (2), 80-7
DOI 10.3109/14017431.2012.756119, PubMed 23301875

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546

Telle-Hansen VH, Narverud I, Retterstøl K, Wesseltoft-Rao N, Mosdøl A, Granlund L, Christiansen KF, Lamglait A, Halvorsen B, Holven KB, Ulven SM (2012)
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
DOI 10.1017/jns.2012.18, PubMed 25191546

Narverud I, Halvorsen B, Nenseter MS, Retterstøl K, Yndestad A, Dahl TB, Ulven SM, Olstad OK, Ose L, Holven KB, Aukrust P (2012)
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB (2012)
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F (2012)
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
DOI 10.2165/11630820-000000000-00000, PubMed 22350498

Græsdal A, Bogsrud MP, Holven KB, Nenseter MS, Narverud I, Langslet G, Brekke M, Retterstøl K, Arnesen KE, Ose L (2012)
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070

Farnier M, Retterstøl K, Steinmetz A, Császár A (2012)
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
DOI 10.1177/1479164111430715, PubMed 22228773

Ottestad I, Vogt G, Retterstøl K, Myhrstad MC, Haugen JE, Nilsson A, Ravn-Haren G, Nordvi B, Brønner KW, Andersen LF, Holven KB, Ulven SM (2011)
Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial
Br J Nutr, 108 (2), 315-26
DOI 10.1017/S0007114511005484, PubMed 22136711

Toleikyte I, Retterstøl K, Leren TP, Iversen PO (2011)
Pregnancy outcomes in familial hypercholesterolemia: a registry-based study
Circulation, 124 (15), 1606-14
DOI 10.1161/CIRCULATIONAHA.110.990929, PubMed 21911783

Skottheim IB, Bogsrud MP, Hermann M, Retterstøl K, Åsberg A (2011)
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy
Mol Diagn Ther, 15 (4), 221-7
DOI 10.1007/BF03256413, PubMed 21815705

Myhrstad MC, Narverud I, Telle-Hansen VH, Karhu T, Lund DB, Herzig KH, Makinen M, Halvorsen B, Retterstøl K, Kirkhus B, Granlund L, Holven KB, Ulven SM (2011)
Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women
Br J Nutr, 106 (12), 1826-35
DOI 10.1017/S0007114511002510, PubMed 21736782

Nenseter MS, Lindvig HW, Ueland T, Langslet G, Ose L, Holven KB, Retterstøl K (2011)
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Atherosclerosis, 216 (2), 426-32
DOI 10.1016/j.atherosclerosis.2011.02.007, PubMed 21376325

Farnier M, Steinmetz A, Retterstøl K, Császár A (2011)
Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study
Clin Ther, 33 (1), 1-12
DOI 10.1016/j.clinthera.2011.02.006, PubMed 21397769

Narverud I, Ueland T, Nenseter MS, Retterstøl K, Telle-Hansen VH, Halvorsen B, Ose L, Aukrust P, Holven KB (2010)
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Atherosclerosis, 214 (1), 163-8
DOI 10.1016/j.atherosclerosis.2010.10.002, PubMed 21040915

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869

Langslet G, Ottestad I, Retterstøl K, Ose L (2010)
[Clinical trials--viewpoints from participants]
Tidsskr Nor Laegeforen, 130 (16), 1606-8
DOI 10.4045/tidsskr.09.0030, PubMed 20805857

Bogsrud MP, Ose L, Langslet G, Ottestad I, Strøm EC, Hagve TA, Retterstøl K (2010)
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Scand Cardiovasc J, 44 (4), 197-200
DOI 10.3109/14017431003624123, PubMed 20636227

Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P, Nenseter MS (2009)
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Retterstøl K, Hennig CB, Iversen PO (2009)
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
DOI 10.1016/j.clnu.2009.01.018, PubMed 19232793

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234

Nenseter MS, Ueland T, Retterstøl K, Strøm E, Mørkrid L, Landaas S, Ose L, Aukrust P, Holven KB (2008)
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
DOI 10.1161/STROKEAHA.108.522995, PubMed 19008470

Blom DJ, Marais AD, Retterstøl K, Stein EA, Ycas J, Gu Z, Miller E (2008)
Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
J Clin Lipidol, 2 (6), 418-25
DOI 10.1016/j.jacl.2008.10.002, PubMed 21291775

Holven KB, Aukrust P, Retterstøl K, Otterdal K, Bjerkeli V, Ose L, Nenseter MS, Halvorsen B (2008)
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
DOI 10.3945/jn.108.090704, PubMed 18936200

Retterstøl K (2008)
[The zero vision for arteriosclerotic cardiovascular disease in younger people]
Tidsskr Nor Laegeforen, 128 (10), 1188-90
PubMed 18480870

Tonstad S, Retterstøl K, Ose L, Ohman KP, Lindberg MB, Svensson M (2007)
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
DOI 10.1016/j.metabol.2007.05.003, PubMed 17697874

Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P (2007)
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692

Bogsrud MP, Sogstad A, Retterstøl K (2007)
[Practical advice for registration of clinical trials]
Tidsskr Nor Laegeforen, 127 (12), 1654-6
PubMed 17571106

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186

Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K (2006)
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
DOI 10.1016/j.clpt.2006.02.014, PubMed 16765141

Holven KB, Halvorsen B, Bjerkeli V, Damås JK, Retterstøl K, Mørkrid L, Ose L, Aukrust P, Nenseter MS (2006)
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
DOI 10.1161/01.STR.0000226465.84561.cb, PubMed 16728689

Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstøl K (2006)
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729

Holven KB, Aukrust P, Retterstol K, Hagve TA, Mørkrid L, Ose L, Nenseter MS (2006)
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
DOI 10.1080/00335510500429821, PubMed 16464786

Westerberg R, Månsson JE, Golozoubova V, Shabalina IG, Backlund EC, Tvrdik P, Retterstøl K, Capecchi MR, Jacobsson A (2005)
ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue
J Biol Chem, 281 (8), 4958-68
DOI 10.1074/jbc.M511588200, PubMed 16326704

Retterstøl K, Haugen TB, Tran TN, Christophersen BO (2001)
Studies on the metabolism of essential fatty acids in isolated human testicular cells
Reproduction, 121 (6), 881-7
DOI 10.1530/rep.0.1210881, PubMed 11373174

Retterstøl K, Tran TN, Haugen TB, Christophersen BO (2001)
Metabolism of very long chain polyunsaturated fatty acids in isolated rat germ cells
Lipids, 36 (6), 601-6
DOI 10.1007/s11745-001-0763-z, PubMed 11485164

Tran TN, Retterstøl K, Christophersen BO (2001)
Differences in the conversion of the polyunsaturated fatty acids [1-(14)C]22:4(n-6) and [1-(14)C]22:5(n-3) to [(14)C]22:5(n-6) and [(14)C]22:6(n-3) in isolated rat hepatocytes
Biochim Biophys Acta, 1532 (1-2), 137-47
DOI 10.1016/s1388-1981(01)00127-5, PubMed 11420183

Retterstøl K, Lund AM, Tverdal S, Cristophersen BO (2000)
Metabolism of some radiolabeled essential fatty acids in isolated rat hepatocytes is affected by dietary ethanol
Alcohol, 21 (1), 19-26
DOI 10.1016/s0741-8329(99)00097-x, PubMed 10946154

Retterstøl K, Haugen TB, Christophersen BO (2000)
The pathway from arachidonic to docosapentaenoic acid (20:4n-6 to 22:5n-6) and from eicosapentaenoic to docosahexaenoic acid (20:5n-3 to 22:6n-3) studied in testicular cells from immature rats
Biochim Biophys Acta, 1483 (1), 119-31
DOI 10.1016/s1388-1981(99)00166-3, PubMed 10601701

Retterstøl K, Lund AM, Tverdal S, Christophersen BO (1999)
The metabolism of essential fatty acids in rat liver is influenced more by dietary fat than dietary ethanol
Lipids, 34 Suppl, S133-4
DOI 10.1007/bf02562262, PubMed 10419122

Woldseth B, Retterstøl K, Christophersen BO (1998)
Monounsaturated trans fatty acids, elaidic acid and trans-vaccenic acid, metabolism and incorporation in phospholipid molecular species in hepatocytes
Scand J Clin Lab Invest, 58 (8), 635-45
DOI 10.1080/00365519850186067, PubMed 10088200

Retterstøl K, Haugen TB, Woldseth B, Christophersen BO (1998)
A comparative study of the metabolism of n-9, n-6 and n-3 fatty acids in testicular cells from immature rat
Biochim Biophys Acta, 1392 (1), 59-72
DOI 10.1016/s0005-2760(98)00021-6, PubMed 9593823

Retterstøl K, Stugaard M, Gørbitz C, Ose L (1996)
Results of intensive long-term treatment of familial hypercholesterolemia
Am J Cardiol, 78 (12), 1369-74
DOI 10.1016/s0002-9149(96)00649-2, PubMed 8970408

Retterstøl K, Woldseth B, Christophersen BO (1996)
The metabolism of 22:5(-6) and of docosahexaenoic acid [22:6(-3)] compared in rat hepatocytes
Biochim Biophys Acta, 1303 (3), 180-6
DOI 10.1016/0005-2760(96)00087-2, PubMed 8908151

Retterstøl K, Woldseth B, Christophersen BO (1995)
Studies on the metabolism of [1-14C]5.8.11-eicosatrienoic (Mead) acid in rat hepatocytes
Biochim Biophys Acta, 1259 (1), 82-8
DOI 10.1016/0005-2760(95)00150-b, PubMed 7492619

Everts ME, Retterstøl K, Clausen T (1988)
Effects of adrenaline on excitation-induced stimulation of the sodium-potassium pump in rat skeletal muscle
Acta Physiol Scand, 134 (2), 189-98
DOI 10.1111/j.1748-1716.1988.tb08479.x, PubMed 2852445

Review articles

Mundal L, Retterstøl K (2016)
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Curr Opin Lipidol, 27 (4), 388-97
DOI 10.1097/MOL.0000000000000300, PubMed 27070076

Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB (2014)
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240

Myhrstad MC, Retterstøl K, Telle-Hansen VH, Ottestad I, Halvorsen B, Holven KB, Ulven SM (2011)
Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
Inflamm Res, 60 (4), 309-19
DOI 10.1007/s00011-010-0302-5, PubMed 21229287

Hexeberg S, Retterstøl K (2004)
[Hypertriglyceridemia--diagnostics, risk and treatment]
Tidsskr Nor Laegeforen, 124 (21), 2746-9
PubMed 15534665

Other articles

Kolset SO, Nordstrøm M, Hope S, Retterstøl K, Iversen PO (2018)
Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1268, PubMed 29899685

Hope S, Nordstrom M, Retterstol K, Iversen PO, Kolset SO (2018)
The right to a health promoting diet for people with intellectual disabilities
Tidsskr. Nor. Laegeforen., 138 (2), 122-123

Svendsen K, Arnesen E, Retterstøl K (2017)
Saturated fat -a never ending story?
Food Nutr Res, 61 (1), 1377572
DOI 10.1080/16546628.2017.1377572, PubMed 29056889

Holmsen ST, Bakkebø T, Seferowicz M, Retterstøl K (2017)
Statins and breastfeeding in familial hypercholesterolaemia
Tidsskr Nor Laegeforen, 137 (10), 686-687
DOI 10.4045/tidsskr.16.0838, PubMed 28551957

Retterstol K (2017)
More harm than benefit - how much should the patients know?
Tidsskr. Nor. Laegeforen., 137 (9), 598

Retterstøl K (2017)
Re: Mer til skade enn til gagn – hvor mye skal pasientene vite?
Tidsskr Nor Laegeforen, 137 (9), 598
DOI 10.4045/tidsskr.17.0295, PubMed 28468458

Bogsrud MP, Græsdal A, Retterstøl K, Holven KB (2017)
A physically fit woman in her thirties with exertional dyspnoea
Tidsskr Nor Laegeforen, 137 (6), 456-458
DOI 10.4045/tidsskr.16.0538, PubMed 28332800

Christensen JJ, Osnes L, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Data Brief, 10, 587-592
DOI 10.1016/j.dib.2016.12.042, PubMed 28070551

Retterstøl K (2016)
K. Retterstøl svarer
Tidsskr Nor Laegeforen, 136 (18), 1508
DOI 10.4045/tidsskr.16.0793, PubMed 27731589

Retterstøl K (2016)
[Myocardial infarction, saturated fat and cholesterol]
Tidsskr Nor Laegeforen, 136 (14-15), 1205
DOI 10.4045/tidsskr.16.0575, PubMed 27554559

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K (2016)
Low-carbohydrate diets increase LDL-cholesterol, and thereby indicate increased risk of CVD
Br J Nutr, 115 (12), 2264-6
DOI 10.1017/S0007114516001343, PubMed 27376624

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2015)
[Increased mortality in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 135 (11), 1024-5
DOI 10.4045/tidsskr.15.0244, PubMed 26080775

Retterstol K (2015)
Nutrition and remembrance
Tidsskr. Nor. Laegeforen., 135 (6), 578

Baumann M, Espeland MZ, Kværner AS, Bogsrud MP, Retterstøl K (2013)
[M. Baumann and colleagues replies]
Tidsskr Nor Laegeforen, 133 (16), 1685-6
DOI 10.4045/tidsskr.13.1023, PubMed 24005696

Ottestad I, Retterstøl K, Myhrstad MC, Andersen LF, Vogt G, Nilsson A, Borge GI, Nordvi B, Brønner KW, Ulven SM, Holven KB (2012)
Intake of oxidised fish oil does not affect circulating levels of oxidised LDL or inflammatory markers in healthy subjects
Nutr Metab Cardiovasc Dis, 23 (1), e3-4
DOI 10.1016/j.numecd.2012.08.009, PubMed 23146358

Retterstøl K (2012)
[Omega-3 fatty acids--both food and medicine]
Tidsskr Nor Laegeforen, 132 (20), 2258
DOI 10.4045/tidsskr.12.1006, PubMed 23736186

Retterstøl K (2009)
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
Expert Opin Investig Drugs, 18 (9), 1405-11
DOI 10.1517/13543780903164205, PubMed 19678802

Retterstøl K (2005)
Too low blood cholesterol?
Scand J Clin Lab Invest, 65 (1), 1-2
DOI 10.1080/00365510510013488, PubMed 15859021

Theses

Retterstøl K (2000)
Studies on the metabolism of polyunsaturated fatty acids in liver and testicular cells: elongation, desaturation and esterification : the regulation of the formation of 22:5(N-6) and 22:6(N-3)
Institute of Clinical Biochemistry, University of Oslo, Rikshospitalet, Oslo, 1 b. (flere pag.)
BIBSYS 001108654, ISBN 82-7633-143-2

Page visits: 4320